Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis Who Are Treated With Interferon-beta
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01252355
Completado
Fase 3
ClinicalTrials.gov
A Single-arm, Prospective, Multicentre, Open-label Study to Evaluate Ofatumumab Treatment Effectiveness and Patient-reported Outcomes (PRO) in Patients With Relapsing Multiple Sclerosis (RMS) Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod
INTERVENTIONAL
Inicio: 14 de jul de 2020
ID: NCT04353492
Terminado
ClinicalTrials.gov
Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation (The PLEA Trial)
INTERVENTIONAL
Inicio: 16 de ene de 2020
ID: NCT04216667
Completado
ClinicalTrials.gov
Observational Study to Determine the Relationship Between the Degree of Disability and the Presence of Sexual Dysfunction and Between Sexual Dysfunction and the Quality of Life in Patients With Multiple Sclerosis (RRMS)
OBSERVATIONAL
Inicio: 1 de nov de 2008
ID: NCT01080053
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Chronic Painful Diabetic Peripheral Neuropathy (DPN).
INTERVENTIONAL
Inicio: 1 de jul de 2006
ID: NCT00348894
Terminado
Fase 2
ClinicalTrials.gov
A Double-blind, Placebo-controlled, Randomized Dose-ranging Trial to Investigate Efficacy and Safety of Intravenous MIJ821 Infusion in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
INTERVENTIONAL
Inicio: 20 de jul de 2021
ID: NCT04722666
Completado
Fase 1 temprana
ClinicalTrials.gov
Phase 1 Trial of the Implementation of an Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
INTERVENTIONAL
Inicio: 1 de oct de 2023
ID: NCT06334796
Reclutando
Fase 3
ClinicalTrials.gov
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis
INTERVENTIONAL
Inicio: 13 de dic de 2023
ID: NCT06141473
Completado
ClinicalTrials.gov
Registry That Aims to Understand the Definition Used and Treatment Options Utilized by Clinicials for CRT Non-responders
OBSERVATIONAL
Inicio: 1 de ene de 2013
ID: NCT01805154
Completado
Fase 3
ClinicalTrials.gov
A Single Arm, Open-label, Multicenter Study Evaluating the Long-term Safety and Tolerability of 0.5 mg Fingolimod (FTY720) Administered Orally Once Daily in Patients With Relapsing Forms of Multiple Sclerosis
INTERVENTIONAL
Inicio: 13 de sept de 2010
ID: NCT01201356
Completado
Fase 3
ClinicalTrials.gov
Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients With Type 1 Diabetes
INTERVENTIONAL
Inicio: 1 de jun de 2007
ID: NCT00487240
Completado
ClinicalTrials.gov
International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring
OBSERVATIONAL
Inicio: 1 de nov de 2015
ID: NCT02577835
Terminado
Fase 4
ClinicalTrials.gov
Randomized, Double Blind, Placebo Controlled, Two Parallel Group Study to Evaluate the Efficacy and Safety of Piracetam, 12 g Intravenous (IV) Infusion Within 7 Hour (h) Post Stroke Onset, Followed by 12 g/d for 4 Weeks (IV Ampoules, Oral Solution) and 4.8 g/d for 8 Weeks (Tablets) in Adult Subjects With an Acute Ischemic Middle Cerebral Artery Stroke
INTERVENTIONAL
Inicio: 1 de ago de 1998
ID: NCT01883011
Reclutando
ClinicalTrials.gov
Effect of Consumption of a Dairy Product Designed for Pregnant and Lactating Women on the Composition of Human Milk. A Quasi-experimental Study in a Vulnerable Population
INTERVENTIONAL
Inicio: 1 de ago de 2025
ID: NCT07173881
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Compare Cessation Versus Continuation of Long-term Mepolizumab Treatment in Patients With Severe Eosinophilic Asthma (201810)
INTERVENTIONAL
Inicio: 7 de ene de 2016
ID: NCT02555371
Completado
Fase 3
ClinicalTrials.gov
A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial
INTERVENTIONAL
Inicio: 29 de may de 2014
ID: NCT02135692
Por invitación
ClinicalTrials.gov
Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study
OBSERVATIONAL
Inicio: 1 de sept de 2024
ID: NCT07124377
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients With Primary Progressive Multiple Sclerosis.
INTERVENTIONAL
Inicio: 26 de oct de 2020
ID: NCT04544449
Por invitación
Fase 2
ClinicalTrials.gov
A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy
INTERVENTIONAL
Inicio: 30 de jul de 2024
ID: NCT06443463
Completado
Fase 3
ClinicalTrials.gov
A 4-month, Open-label, Multi-center Study to Explore the Safety and Tolerability of Fingolimod 0.5 mg in Patients With Relapsing-remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01497262
Anterior
1
...
21
22
23
...
434
Siguiente
Filtros